Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Abdominal Surgery
NCT07709598 is registered in ClinicalTrials.gov with Shanghai Huilun Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Abdominal Surgery
- Lead sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- May 11, 2026
- Completion date
- December 31, 2026
- Enrollment
- 330 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.